A股異動 | 炬華科技(300360.SZ)漲近8% 中標約3.88億元的國家電網採購項目
格隆匯11月25日丨炬華科技(300360.SZ)股價快速拉昇,最高見14.4元,創2017年3月份以來新高,現報14.34元,漲幅7.9%,總市值72.3億,換手率8.8%。公司收到中標通知書,通知公司為“國家電網有限公司2021年第四十八批採購(營銷項目第二次電能表(含用電信息採集)招標採購)”(招標編號:0711-21OTL14422021)中標單位,共中12個包,合計總數量110.6073萬隻,總金額約3.88億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.